Коклюш

Список литературы

Основные статьи

Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005 Apr;18(2):326-82. Аннотация

Статьи, указанные как источники

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005 Apr;18(2):326-82. Аннотация

2. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018 Apr 27;67(2):1-44.Полный текст  Аннотация

3. Public Health England. Guidelines for the public health management of pertussis in England. May 2018 [internet publication].Полный текст

4. Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010 Nov 12;330(6006):982-5. Аннотация

5. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011 Sep;3(3-4):183-8. Аннотация

6. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect. 2014 Apr;142(4):672-84. Аннотация

7. Cherry JD. Epidemic pertussis in 2012: the resurgence of a vaccine-preventable disease. N Engl J Med. 2012 Aug 30;367(9):785-7.Полный текст  Аннотация

8. Lavine J, Broutin H, Harvill ET, et al. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine. 2010 Dec 10;29(1):11-6.Полный текст  Аннотация

9. McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015 Feb;135(2):331-43.Полный текст  Аннотация

10. Domenech de Cellès M, Magpantay FMG, King AA, Rohani P. The impact of past vaccination coverage and immunity on pertussis resurgence. Sci Transl Med. 2018 Mar 28;10(434).Полный текст  Аннотация

11. World Health Organization. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010 Oct 1;85(40):385-400.Полный текст  Аннотация

12. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics. 2005 May;115(5):1422-7. Аннотация

13. Tan T, Trindade E, Skowronsk D. Epidemiology of pertussis. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S10-8. Аннотация

14. Public Health England. Pertussis: laboratory confirmed cases reported in England 2016. March 2017 [internet publication].Полный текст

15. Galanis E, King AS, Varughese P, et al. Changing epidemiology and emerging risk groups for pertussis. CMAJ. 2006 Feb 14;174(4):451-2. Аннотация

16. Cherry JD, Grimprel E, Guiso N, et al. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005 May;24(5 Suppl):S25-34. Аннотация

17. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S104-8. Аннотация

18. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J. 2006 Apr;25(4):361-2. Аннотация

19. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 1999 Jun;28 Suppl 2:S112-7. Аннотация

20. Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr. 2008 Feb;167(2):133-9. Аннотация

21. Centers for Disease Control and Prevention. 2016 Final pertussis surveillance report. January 2018 [internet publication].Полный текст

22. Hamborsky J, Kroger A, Wolfe S, eds. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington D.C.: Public Health Foundation; 2015.Полный текст

23. Wang K, Bettiol S, Thompson MJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2014 Sep 22;2014(9):CD003257.Полный текст  Аннотация

24. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics. 2015 Oct;136(4):635-41.Полный текст  Аннотация

25. Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol. 2012 May;20(5):211-3. Аннотация

26. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007 Apr;26(4):293-9. Аннотация

27. Cortese MM, Baughman AL, Brown K, et al. A "new age" in pertussis prevention new opportunities through adult vaccination. Am J Prev Med. 2007 Mar;32(3):177-85. Аннотация

28. Hallander HO, Gnarpe J, Gnarpe H, et al. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand J Infect Dis. 1999;31(3):281-6. Аннотация

29. Gregory DS. Pertussis: a disease affecting all ages. Am Fam Physician. 2006 Aug 1;74(3):420-6. Аннотация

30. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000 Jul;182(1):174-9. Аннотация

31. Elahi S, Buchanan RM, Babiuk LA, et al. Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun. 2006 May;74(5):2619-27.Полный текст  Аннотация

32. Centers for Disease Control and Prevention; Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings (2007). Jul 2019 [internet publication].Полный текст

33. Centers for Disease Control and Prevention. Pertussis (whooping cough): Clinicians. 2019 [internet publication].Полный текст

34. Zhang L, Prietsch SO, Axelsson I, et al. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 2014 Sep 17;(9):CD001478.Полный текст  Аннотация

35. Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2020. Feb 2020 [internet publication].Полный текст

36. Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States, 2020. Feb 2020 [internet publication].Полный текст

37. Havers FP, Moro PL, Hunter P, et al. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Jan 24;69(3):77-83.Полный текст  Аннотация

38. Public Health England. Vaccination against pertussis (whooping cough) for pregnant women. June 2016 [internet publication].Полный текст

39. Committee on Obstetric Practice, Immunization and Emerging Infections Expert Work Group. Committee Opinion No. 718: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2017 Sep;130(3):e153-7. Полный текст  Аннотация

40. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011 Jan 15;52(2):157-62.Полный текст  Аннотация

41. Pichichero ME, Casey JR, Almudevar A. Nonprotective responses to pediatric vaccines occur in children who are otitis prone. Pediatr Infect Dis J. 2013 Nov;32(11):1163-8. Аннотация

42. Cornia PB, Hersh AL, Lipsky BA, et al. Does this coughing adolescent or adult patient have pertussis? JAMA. 2010 Aug 25;304(8):890-6. Аннотация

43. Centers for Disease Control and Prevention. Pertussis (whooping cough): Clinicians. August 2017 [internet publication].Полный текст

44. Tozzi AE, Rava L, Ciofi degli Atti ML, et al, the Progetto Pertosse Working Group. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics. 2003 Nov;112(5):1069-75. Аннотация

45. Centers for Disease Control and Prevention. Pertussis (whooping cough): treatment. 2019 [internet publication].Полный текст

46. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 10: pertussis. November 2017 [internet publication].Полный текст

47. World Health Organization. WHO-recommended surveillance standard of pertussis. Jul 2019 [internet publication].Полный текст

48. Palmer CM, McCall B, Jarvinen K, et al. Bordetella pertussis PCR positivity, following onset of illness in children under 5 years of age. Commun Dis Intell. 2007 Jun;31(2):202-5. Аннотация

49. Loeffelholz MJ, Thompson CJ, Long KS, et al. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol. 1999 Sep;37(9):2872-6.Полный текст  Аннотация

50. Heininger U, Schmidt-Schlapfer G, Cherry JD, et al. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics. 2000 Mar;105(3):E31. Аннотация

51. Doern GV. Detection of selected fastidious bacteria. Clin Infect Dis. 2000 Jan;30(1):166-73.Полный текст  Аннотация

52. Litt DJ, Samuel D, Duncan J, et al. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J Med Microbiol. 2006 Sep;55(Pt 9):1223-8. Аннотация

53. Miyashita N, Akaike H, Teranishi H, et al. Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients. BMC Infect Dis. 2013 Mar 11;13:129.Полный текст  Аннотация

54. Dragsted DM, Dohn B, Madsen J, et al. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol. 2004 Aug;53(Pt 8):749-54. Аннотация

55. Murray EL, Nieves D, Bradley JS, et al. Characteristics of severe bordetella pertussis infection among infants ≤90 days of age admitted to pediatric intensive care units – southern California, September 2009–June 2011. J Ped Infect Dis. 2013 Mar;2(1):1-6.

56. Raguckas SE, VandenBussche HL, Jacobs C, et al. Pertussis resurgence: diagnosis, treatment, prevention, and beyond. Pharmacotherapy. 2007 Jan;27(1):41-52. Аннотация

57. Brown MO, St. Anna L, Ohl M. Clinical inquiries. What are the indications for evaluating a patient with cough for pertussis? J Fam Pract. 2005 Jan;54(1):74-6. Аннотация

58. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004404.Полный текст  Аннотация

59. Alvarez-Elcoro S, Enzler MJ. The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc. 1999 Jun;74(6):613-34. Аннотация

60. Halperin SA, Bortolussi R, Langley JM, et al. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection. Pediatrics. 1999 Oct;104(4):e42. Аннотация

61. von König CH, Halperin S, Riffelmann M, et al. Pertussis of adults and infants. Lancet Infect Dis. 2002 Dec;2(12):744-50. Аннотация

62. Centers for Disease Control and Prevention. Pertussis (whooping cough): surveillance and reporting. 2019 [internet publication].Полный текст

63. Centers for Disease Control and Prevention. Pertussis (whooping cough): postexposure antimicrobial prophylaxis. 2019 [internet publication].Полный текст

64. Centers for Disease Control and Prevention; Healthcare Infection Control Practices Advisory Committee (HICPAC). 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. 2007 [internet publication].Полный текст

65. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev. 2008 Sep;9(3):201-11. Аннотация

Использование этого контента попадает под действие нашего заявления об отказе от ответственности